Table 2.
Summary of multivariate analysis
| Regression coefficient | Standard error | p value | Adjusted R2 | |
|---|---|---|---|---|
| Maximum dose | ||||
| TZa | 6.276 | 1.823 | 0.0010 | |
| CTRb | 0.246 | 0.198 | 0.2185 | 0.221 |
| BMIc | –0.556 | 0.223 | 0.0154 | |
| Mean dose | ||||
| TZa | 6.512 | 1.661 | 0.0002 | |
| CTRb | 0.087 | 0.180 | 0.6309 | 0.219 |
| BMIc | –0.391 | 0.203 | 0.0595 | |
| V20Gyd | ||||
| TZa | 13.313 | 4.069 | 0.0018 | |
| CTRb | 0.456 | 0.441 | 0.3054 | 0.191 |
| BMIc | –1.116 | 0.498 | 0.0287 | |
| V30Gyd | ||||
| TZa | 17.066 | 4.172 | 0.0001 | |
| CTRb | 0.146 | 0.452 | 0.7484 | 0.243 |
| BMIc | –1.115 | 0.511 | 0.0329 | |
| V40Gyd | ||||
| TZa | 17.190 | 4.101 | < 0.0001 | |
| CTRb | –0.086 | 0.444 | 0.8478 | 0.275 |
| BMIc | –0.973 | 0.502 | 0.0572 |
a TZ = transition zone; b CTR = cardiothoracic ratio; c BMI = body mass index;
d V20Gy, V30Gy, and V40Gy = percentage of left anterior descending artery volume receiving ≥ 20, ≥ 30, and ≥ 40 Gy, respectively.